Answer
Women of childbearing potential should use effective contraception during sotatercept treatment and for at least 4 months after the last dose if treatment is discontinued.
Sources for this answer
- Winrevair 45 mg powder and solvent for solution for injectionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked